Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 265

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Prognostic Factors in Primary Cutaneous Large B-Cell Lymphomas: A European Multicenter Study

Grange, F., Bekkenk, M. W., Wechsler, J., Meijer, C. J.L.M., Cerroni, L., Bernengo, M., Bosq, J., Hedelin, G., Fink Puches, R., van Vloten, W. A., Joly, P., Bagot, M., Willemze, R. · 2001 · Journal of Clinical Oncology

Abstract

PURPOSE: Most primary cutaneous B-cell lymphomas have an excellent prognosis. However, primary cutaneous large B-cell lymphomas (PCLBCLs) of the leg have been recognized as a distinct entity with a poorer prognosis in the European Organization for Research and Treatment of Cancer (EORTC) classification. This distinction on the basis of site has been debated. Our aim was to identify independent prognostic factors in a large European multicenter series of PCLBCL. PATIENTS AND METHODS: The clinical and histologic data of 145 patients with PCLBCL were evaluated. According to the EORTC classification, 48 patients had a PCLBCL of the leg and 97 had a primary cutaneous follicle center-cell lymphoma (PCFCCL). Data from both groups were compared. Univariate and multivariate analyses of specific survival were performed using a Cox proportional hazards model. RESULTS: Compared with PCFCCL, PCLBCL-leg were characterized by an older age of onset, a more recent history of skin lesions, a more frequent predominance of tumor cells with round nuclei and positive bcl-2 staining, and a poorer 5-year disease-specific survival rate (52% v 94%; P < .0001). Univariate survival analysis in the entire study group showed that older age, a more recent onset of skin lesions, the location on the leg, multiple skin lesions, and the round-cell morphology were significantly related to death. In multivariate analysis, the round-cell morphology (P < .0001), the location on the leg (P = .002), and multiple skin lesions (P = .01) remained independent prognostic factors. The round-cell morphology was an adverse prognostic factor both in PCLBCL-leg and in PCFCCL, whereas multiple skin lesions were associated with a poor prognosis only in patients with PCLBCL-leg. CONCLUSION: With site, morphology, and number of tumors taken into account, guidelines for the management of PCLBCL are presented.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2001.19.16.3602

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 265

Metadata

Authors
Grange, F., Bekkenk, M. W., Wechsler, J., Meijer, C. J. L. M., Cerroni, L., Bernengo, M., Bosq, J., Hedelin, G., Fink Puches, R., van Vloten, W. A., Joly, P., Bagot, M., & Willemze, R.
Venue
Journal of Clinical Oncology
Published
2001-08-15
Volume
19
Issue
16
Pages
3602-3610
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W1925693065
Cited by
265
References
13
FWCI
14.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic Factors in Primary Cutaneous Large B-Cell Lymphomas: A European Multicenter Study. https://app.cochat.ai/papers/10.1200/jco.2001.19.16.3602
The paper
Grange, F., Bekkenk, M. W., Wechsler, J., Meijer, C. J. L. M., Cerroni, L., Bernengo, M., Bosq, J., Hedelin, G., Fink Puches, R., van Vloten, W. A., Joly, P., Bagot, M., & Willemze, R. (2001). Prognostic Factors in Primary Cutaneous Large B-Cell Lymphomas: A European Multicenter Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2001.19.16.3602

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.